Search for Clinical Trial Results

Sponsored By

Bourneville Syndrome - 17 Studies Found

Status Study
Recruiting Study Name: A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous Sclerosis
Condition: Tuberous Sclerosis
Date: 2013-09-05
Interventions:
  • Drug: Placebo 5mg daily admini
Active, not recruiting Study Name: Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Condition: Tuberous Sclerosis Complex
Date: 2013-01-28
Completed Study Name: Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC)
Condition: Tuberous Sclerosis Complex
Date: 2011-02-02
Interventions: Drug: RAD001 RAD001 is formulated as tablets of 5.0 mg str
Recruiting Study Name: Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex
Condition: Tuberous Sclerosis Complex
Date: 2016-02-10
Interventions: Behavioral: JASPER JASPER (Joint Attention, Symbolic Play, Engagement, and Regulation) is a treatment ap
Recruiting Study Name: Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex
Condition: Tuberous Sclerosis Complex
Date: 2016-07-13
Interventions:
  • Drug: Vigabatrin Subjects rand
Completed Study Name: Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex
Condition:
  • Tuberous Sclerosis
  • Subependymal Giant Cell Astrocytoma
    • Date: 2006-12-12
    Interventions: Drug: Everolimus Initial everolimus dosage will be 3 mg/m2/d taken daily or every other day, with titrat
Active, not recruiting Study Name: A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Condition: Tuberous Sclerosis Complex-associated Refractory Seizures
Date: 2012-10-09
Interventions:
  • Drug: RAD001 Other Name: Afini
Active, not recruiting Study Name: Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM
Condition:
  • Tuberous Sclerosis
  • Lymphangioleiomyomatosis

Date: 2007-06-21
Interventions: Drug: sirolimus daily oral sirolimus with dosage individualised by trough blood levels
Completed Study Name: Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
Condition:
  • Epilepsy
  • Tuberous Sclerosis Complex

Date: 2010-02-15
Interventions: Drug: Everolimus Everolimus is available in tablet form. The starting dose will be 5 mg/m2/day, rounded
Completed Study Name: Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
Condition:
  • Tuberous Sclerosis
  • Subependymal Giant Cell Astrocytoma
    • Date: 2008-11-12
    Interventions:
    • Drug: Everolimus Everolimus wa
Next >>>